Novo Nordisk, AWS Partner on AI Drug Discovery

Novo Nordisk is deepening its push into artificial intelligence through a new strategic partnership with Amazon Web Services. The collaboration aims to accelerate drug discovery and expand the use of AI across the pharmaceutical company.

The collaboration includes a new co-innovation hub at Novo Nordisk’s facility in London. There, AWS engineers, AI specialists and scientists will work with the pharma giant’s research teams to analyze scientific data and help accelerate drug discovery.